Effect of Intensive Therapy Associated With CSII on β-cell Function With Newly Diagnosed Type 2 Diabetes
Status:
Suspended
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate and evaluate the effects of different
interventions (1.continuous subcutaneous insulin infusion,2.continuous subcutaneous insulin
infusion combined with rosiglitazone 3.continuous subcutaneous insulin infusion combined with
metformin,4.continuous subcutaneous insulin infusion combined with α- thioctic acid daily
injections,) on glycemic control, B-cell function and the remission rate in newly-diagnosed
type 2 diabetic patients.